All Posts By

Smartkarma Daily Briefs

Daily Brief Credit: Morning Views Asia: ABM Investama and more

By | Credit, Daily Briefs

In today’s briefing:

  • Morning Views Asia: ABM Investama, NagaCorp Ltd, Times China, Yuexiu Property

Morning Views Asia: ABM Investama, NagaCorp Ltd, Times China, Yuexiu Property

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: Blibli IPO: Trading Debut and more

By | Daily Briefs, ECM

In today’s briefing:

  • Blibli IPO: Trading Debut
  • I-Tail Corporation IPO: The Bull Case

Blibli IPO: Trading Debut

By Arun George


I-Tail Corporation IPO: The Bull Case

By Arun George

  • I-Tail (ITC TB), Thai Union Group (TU TB)’s pet care division, has started pre-marketing an up to US$600 million SET IPO, according to press reports.
  • I-Tail is one of the largest original equipment manufacturers (OEMs) for wet cat & dog food in Asia, according to Frost & Sullivan.
  • The key elements of the bull case rest on strong top-line growth, market share gains, ambitious growth plans and the highest margin profile among peers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Macro: Hawkish Fed Faces New Challenge as US Treasury Examines Ways to Improve Market Liquidity and more

By | Daily Briefs, Macro

In today’s briefing:

  • Hawkish Fed Faces New Challenge as US Treasury Examines Ways to Improve Market Liquidity
  • The Hidden Story of Investor Capitulation
  • Peering into 2023: A Bear Market Roadmap

Hawkish Fed Faces New Challenge as US Treasury Examines Ways to Improve Market Liquidity

By Said Desaque

  • US financial markets have been persistently wrong to entertain thoughts of an early dovish pivot to Fed policy conduct without unambiguous evidence of returning price stability. 
  • The Fed’s pursuit of quantitative tightening will raise the federal budget deficit via higher net interest costs and lower tax revenues due to slower economic growth. 
  • Diminishing liquidity in the US Treasury market could force a bond buyback programme that potentially complicates the Fed’s quantitative tightening programme due to its impact on bank reserves

The Hidden Story of Investor Capitulation

By Cam Hui

  • The good news is that retail sentiment is more washed out than generally believed.
  • The bad news is the stock market faces a number of short-term challenges in November.
  • Uncertainty over the midterm election and a possible fiscal fallout, a likely hot CPI report and bearish World Cup seasonality will create headwinds for stock prices.

Peering into 2023: A Bear Market Roadmap

By Cam Hui

  • The Fed has made it clear that it wants to tighten monetary conditions by engineering an equity bear market.
  • Assuming the economy enters recession in Q4 or Q1, history shows that it will emerge within about six months, putting the timing of a bottom at about the same time.
  • The S&P 500 is trading at a forward P/E of 16.1. Assuming a typical 15-20% cut to forward earnings estimates in a recession, this puts the downside potential at 2500–2850.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Equity Bottom-Up: Astra International (ASII IJ) – Driving into Indonesia’s Growth Areas and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Astra International (ASII IJ) – Driving into Indonesia’s Growth Areas
  • Kunlun Energy (135 HK): Kunlun Gas 3Q22 Masked by Non-Operating Factors
  • Akeso Biopharma (9926.HK) – The Recent Business Progress, the Valuation and the Challenges
  • China Internet Weekly (7Nov2022): Tencent, Alibaba, Kuaishou, JD.com, Autohome, China Unicom
  • Deep Dive: Komatsu (6301, KMTUY)
  • REIT Watch – CapitaLand Reits see operational growth in Q3
  • Grounding Myself in this Market Cycle
  • King No More

Astra International (ASII IJ) – Driving into Indonesia’s Growth Areas

By Angus Mackintosh

  • Astra International (ASII IJ)‘s recent 9M2022 numbers confirmed its position as a well-rounded way to play Indonesia’s economic recovery through autos and commodities through its controlling stake in United Tractors.
  • The company has continued to deploy its war chest of funds from the Bank Permata sale, investing in commercial vehicle leasing, hydro-power, and digital banking in 3Q2022 alone.
  • Astra International (ASII IJ trades on 9.0x FY2023 PER and 8.5x FY2024E PER versus its 5-year average forward PER of 14x, making it attractive at current levels. 

Kunlun Energy (135 HK): Kunlun Gas 3Q22 Masked by Non-Operating Factors

By Osbert Tang, CFA

  • 3Q22 result of Kunlun Gas is weaker than expected, but this is due to lower other income and surge in non-operating expenses. Without them, profit growth is actually more encouraging.
  • While there is gross margin squeeze on higher input costs, Kunlun managed to reduce operating costs by 14.1%, successfully mitigated the negative impact.
  • Kunlun Gas contributed 62.5% of 1H22 net profit of Kunlun Energy (135 HK). Its solid 36.2% 9M22 earnings growth still points to healthy underlying momentum for its parent.

Akeso Biopharma (9926.HK) – The Recent Business Progress, the Valuation and the Challenges

By Xinyao (Criss) Wang

  • Akeso has made some business progress. We analyzed the commercialization outlook/concerns on its late stage products. Akeso still stays at the level of biotech, a long way from becoming biopharma.
  • The core challenge is whether bispecific antibody can bring better marginal clinical benefits than the combination of two mab, and why patients are willing to pay higher price for them?
  • The sales forecast of Akeso’s late stage products could be RMB2 billion to RMB3 billion. The market value by the end of Nov 4 was just reasonable but not undervalued.

China Internet Weekly (7Nov2022): Tencent, Alibaba, Kuaishou, JD.com, Autohome, China Unicom

By Ming Lu

  • Tencent and Alibaba are rumored to be acquired by state-owned companies.
  • Tencent charges for originally free function and JD.com re-organized to cut cost.
  • Autohome’s revenue stopped declining in 3Q22 and it is time to accumulate.

Deep Dive: Komatsu (6301, KMTUY)

By Value Punks

  • Industrials have been quite resilient this year. Their stocks prices have run up as sector earnings fared better-than-expected, and as investors have looked for safety under the cover of ‘real economy’ stocks during a year in which tech is down big.
  • You may think that the train has left the station already with blue chip industrials like Caterpillar and Deere.
  • They’re certainly trading near all time highs! But hold on. There is one train which hasn’t left yet, and that is Komatsu.

REIT Watch – CapitaLand Reits see operational growth in Q3

By Geoff Howie

  • REIT Watch – CapitaLand Reits see operational growth in Q3 CLI’s funds business comprises five real estate investment trusts (Reits) and business trusts listed on the Singapore Exchange (SGX).
  • Ascendas Reit is now known as CapitaLand Ascendas Reit; Ascott Residence Trust is now known as CapitaLand Ascott Trust; while Ascendas India Trust is changed to CapitaLand India Trust.

Grounding Myself in this Market Cycle

By BluSuit

  • At the moment of writing this, it’s 2:30 pm on a Sunday and I am in a ground blind. Every year at about this time of the year I take a few days off of work to unplug, have a few drinks with other family members and run off to the middle of the woods.
  • I get some of my best thinking done out here while I wait for a White Tail Buck to come by. It’s blissful.
  • Regardless of where I am or what I am doing, I am and always have been committed to maintaining my transparency, my thoughts and my investing story/process to all of you.

King No More

By subSPAC

  • Fantasy Sportbook Operator DraftKings saw its shares drop by 28% at the close on Friday, recording the worst in its trading history even as its management and CEO remained upbeat about the company’s future.
  • What was surprising about the steep decline was the fact that the company beat analyst expectations both on the revenue and EPS front in its most recent quarter while also raising its full-year guidance.
  • The market remains skeptical about the company’s business model and its decision to prioritize growth over profitability, a stark comparison to its peers who have cut costs in recent months.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Thematic (Sector/Industry): Good Morning Japan (November 7 and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Good Morning Japan (November 7, 2022)
  • Weekly Stock Bullfinder – Week of 11/7

Good Morning Japan (November 7, 2022)

By Mark Chadwick

  • Good Morning Japan: A detailed look at the overnight news and market moves that will impact the trading day in Japan
  • US rally overnight on mixed employment and hopes of easing of China Covid-19 restrictions. China officials pour cold water these hopes – look for reversal 
  • Daikin Nikkei Preview – looks weak; Defense stocks likely gets support; SMBC takes that axe to SMBC Nikko CEO  – harsh.

Weekly Stock Bullfinder – Week of 11/7

By Weekly Stock Bull Finder

  • Michael Kantro (@MichaelKantro), Chief Investment Strategist at Piper Sandler, put together the “HOPE” roadmap to illustrate the chronology of how and where the Federal Reserve’s interest rate hikes ripple through and impact the economy.
  • The order of the HOPE roadmap dictates that the housing market is the first to slow, followed by new orders, then S&P 500 profits, and last is the employment market.
  • The Federal Reserve’s latest increase, the fourth consecutive increase of 75 points, brings the federal funds rate – which acts as a benchmark for everything including business loans, credit card and mortgage rates – to between 3.75% and 4%, the highest level since January 2008.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Event-Driven: MSCI Korea November SAIR: Potential Changes and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • MSCI Korea November SAIR: Potential Changes, Impact, Short Interest & Pre-Positioning
  • Mitsui & Co (8031) Buyback – Big Profit, Big Div, Big Buyback, Some Index Selling
  • MSCI SEA EM Nov SAIR: High Impact Deletions Expected
  • Weekly Deals Digest (06 Nov) – Perpetual, Pendal, Nitro, ReadyTech, VNET, Singapore Medical, Blibli
  • Merger Arb Mondays (07 Nov) – Yashili, Fengxiang, Kingston, Pendal, Perpetual, ReadyTech, Nitro
  • Toshiba (6502) – Funding Deadline Risk Was Known 6+ Weeks Ago
  • EQD | Volatility Update: Weekly Review of Vol Changes and Best Trades
  • MSCI India November SAIR: Potential Changes & Higher Foreign Holding
  • Elliot Tenders Its Stake

MSCI Korea November SAIR: Potential Changes, Impact, Short Interest & Pre-Positioning

By Brian Freitas

  • We see 1 potential inclusion and 12 potential deletions for the MSCI Korea Index at the November SAIR. The final changes will depend on what day MSCI uses.
  • Nearly all the stocks have over 4 days of ADV to trade from passive trackers. There have been big moves on short interest and excess volume on some stocks.
  • The announcement will be made Friday morning pre-market open and there could be some big moves in the stocks this week.

Mitsui & Co (8031) Buyback – Big Profit, Big Div, Big Buyback, Some Index Selling

By Travis Lundy

  • Mitsui & Co Ltd (8031 JP) on 1 November reported its results for H1 2022. H1 Revenue +37.1%yoy, OP+27.2%yoy, NP+33.2%yoy to ¥539bn. Full-year NP forecast +22.5% to ¥980bn.
  • Mitsui raised its dividend forecast (previously scheduled to rise from ¥105/share to ¥120/share) to ¥130/share and announced a ¥140bn buyback, adding to the ¥100bn announced in May completed in September.
  • The first ¥58.6bn was done in a ToSTNeT-3 buyback. Now there is another ¥79.4bn to go. There’s also a fair bit of index selling the next 6mos.

MSCI SEA EM Nov SAIR: High Impact Deletions Expected

By Brian Freitas

  • There should be quite a few deletions for South East Asia Emerging Markets. The number of potential inclusions is smaller and have a smaller probability of being added.
  • While the passive flow on the potential deletions is not massive, the impact in terms of days of ADV to trade is very high in most cases.
  • There has been a steady increase in cumulative excess volume on a few of the potential deletions and there will be unwinding against the passive flow.

Weekly Deals Digest (06 Nov) – Perpetual, Pendal, Nitro, ReadyTech, VNET, Singapore Medical, Blibli

By Arun George


Merger Arb Mondays (07 Nov) – Yashili, Fengxiang, Kingston, Pendal, Perpetual, ReadyTech, Nitro

By Arun George


Toshiba (6502) – Funding Deadline Risk Was Known 6+ Weeks Ago

By Travis Lundy

  • There are several bits of news in the past few weeks indicating financing commitments might not meet the 7 Nov deadline. Principal among them the JIC/JIP split many weeks ago. 
  • That suggested the 30 Sep and subsequent deadlines would be delayed. And it appears we now have the reason for it, and that is another cause of financing commitment delay.
  • This development suggests activists have another quiver in their arrow should privatisation not succeed. Toshiba has cheapened in the meantime.

EQD | Volatility Update: Weekly Review of Vol Changes and Best Trades

By Simon Harris

  • Weekly summary of vol changes and moves across Global Markets
  • Analysing ATM volatility and skew changes over the last 5 days
  • We suggest a few trades to take advantage of the implied vol surfaces

MSCI India November SAIR: Potential Changes & Higher Foreign Holding

By Brian Freitas

  • Post the end of the review period, we see 7 potential adds and 2 potential deletes for the MSCI India Index at the November SAIR.
  • Inclusion in the index will require passive trackers to buy 6-21 days of ADV on the stocks. That increases to 16-45 days of delivery volume.
  • Cumulative excess volume indicates pre-positioning on most potential adds. Foreign Portfolio Investors (FPI) have increased their holding on all potential adds over the July-September quarter.

Elliot Tenders Its Stake

By Jesus Rodriguez Aguilar

  • 4 November was the deadline to tender. PMI threatened to walk away if it didn’t reach 90%. Some funds that opposed the deal trimmed their stakes, likely bought by arbs.
  • The FT has reported that Elliot (10.5% stake) has tendered and that by 4 November over 80% acceptances were recorded. PMI is very likely to reach now over 90% acceptances.
  • Results will be announced on 7 November, with settlement on 11 November. The squeeze-out procedure is likely be initialed as soon as possible after settlement. Gross spread is 0.87%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Most Read: Kawasaki Kisen Kaisha, Toshiba Corp, Yang Ming Marine Transport, Sk Chemicals Co Ltd/New, Mitsui & Co Ltd, Metro Pacific Investments Co, KT Corp, Tencent, Blibli, I-Tail and more

By | Daily Briefs, Most Read

In today’s briefing:

  • KLine (Kawasaki Kisen 9107) Announced Q2 Earnings and Possibly Game-Able Buyback (And Index Impact)
  • Last Week in Event SPACE: Toshiba, Perpetual/Pendal, News Corp/Fox Corp
  • Index Rebalance & ETF Flow Recap: TW Div+, CSI500, ChiNext, SSE180, KS200, KQ150, FTSE CH50, AMFI
  • MSCI Korea November SAIR: Potential Changes, Impact, Short Interest & Pre-Positioning
  • Mitsui & Co (8031) Buyback – Big Profit, Big Div, Big Buyback, Some Index Selling
  • MSCI SEA EM Nov SAIR: High Impact Deletions Expected
  • KOSPI 200 Index Review: Names Subject to Float Rate Adjustment
  • ECM Weekly (6th Nov 2022) – Giant Biogene, Blibli, Betagro, Bionote, Fusion, Medanta, Bikaji, Axis
  • Blibli IPO: Trading Debut
  • I-Tail Corporation IPO: The Bull Case

KLine (Kawasaki Kisen 9107) Announced Q2 Earnings and Possibly Game-Able Buyback (And Index Impact)

By Travis Lundy

  • Strong but slightly disappointing Q2 earnings from Kawasaki Kisen Kaisha (9107 JP), and full-year forecasts are higher, but not as high as consensus. 
  • The company has announced a buyback, to be executed on ToSTNeT-3. Effissimo and Mizuho Bank will participate. Other crossholders could too. 
  • Strategy depends on whether you think they will. If they do not, post-buyback float drops sharply.

Last Week in Event SPACE: Toshiba, Perpetual/Pendal, News Corp/Fox Corp

By David Blennerhassett


Index Rebalance & ETF Flow Recap: TW Div+, CSI500, ChiNext, SSE180, KS200, KQ150, FTSE CH50, AMFI

By Brian Freitas

  • MSCI announces the changes at the November SAIR pre-market open (Asia time) on 11 November. That day is also the market cap cutoff for the FTSE December QIR.
  • There are some pretty big changes to the flows for the FTSE TWSE Taiwan Div+ Index following changes to forward dividend estimates and stock prices.
  • Quiet week for ETF flows with large inflows to Huatai-PB CSI 300 ETF (510300 CH) and Tracker Fund of Hong Kong Ltd (2800 HK)

MSCI Korea November SAIR: Potential Changes, Impact, Short Interest & Pre-Positioning

By Brian Freitas

  • We see 1 potential inclusion and 12 potential deletions for the MSCI Korea Index at the November SAIR. The final changes will depend on what day MSCI uses.
  • Nearly all the stocks have over 4 days of ADV to trade from passive trackers. There have been big moves on short interest and excess volume on some stocks.
  • The announcement will be made Friday morning pre-market open and there could be some big moves in the stocks this week.

Mitsui & Co (8031) Buyback – Big Profit, Big Div, Big Buyback, Some Index Selling

By Travis Lundy

  • Mitsui & Co Ltd (8031 JP) on 1 November reported its results for H1 2022. H1 Revenue +37.1%yoy, OP+27.2%yoy, NP+33.2%yoy to ¥539bn. Full-year NP forecast +22.5% to ¥980bn.
  • Mitsui raised its dividend forecast (previously scheduled to rise from ¥105/share to ¥120/share) to ¥130/share and announced a ¥140bn buyback, adding to the ¥100bn announced in May completed in September.
  • The first ¥58.6bn was done in a ToSTNeT-3 buyback. Now there is another ¥79.4bn to go. There’s also a fair bit of index selling the next 6mos.

MSCI SEA EM Nov SAIR: High Impact Deletions Expected

By Brian Freitas

  • There should be quite a few deletions for South East Asia Emerging Markets. The number of potential inclusions is smaller and have a smaller probability of being added.
  • While the passive flow on the potential deletions is not massive, the impact in terms of days of ADV to trade is very high in most cases.
  • There has been a steady increase in cumulative excess volume on a few of the potential deletions and there will be unwinding against the passive flow.

KOSPI 200 Index Review: Names Subject to Float Rate Adjustment

By Sanghyun Park

  • We have seven constituents of KOSPI 200, which are subject to a float rate adjustment due to major shareholder stake sales and lockup release in the upcoming rebalancing in December
  • In terms of passive impact x ADTV, LG Energy Solution, KT Corp, and Shinhan Financial are expected to receive the most attention from flow traders.
  • The preemptive setups of flow traders will likely be more inclined toward these float rate changes since this December rebalance will have the lowest number of constituent changes ever.

ECM Weekly (6th Nov 2022) – Giant Biogene, Blibli, Betagro, Bionote, Fusion, Medanta, Bikaji, Axis

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • On the IPO front,  a number of companies in India have launched thier IPOs recently, even as HK and rest of Asia remains dormant.
  • The only notable placement this week was the selldown in Axis Bank Ltd (AXSB IN) by Bain Capital.

Blibli IPO: Trading Debut

By Arun George


I-Tail Corporation IPO: The Bull Case

By Arun George

  • I-Tail (ITC TB), Thai Union Group (TU TB)’s pet care division, has started pre-marketing an up to US$600 million SET IPO, according to press reports.
  • I-Tail is one of the largest original equipment manufacturers (OEMs) for wet cat & dog food in Asia, according to Frost & Sullivan.
  • The key elements of the bull case rest on strong top-line growth, market share gains, ambitious growth plans and the highest margin profile among peers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Australia: Perpetual Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • (Mostly) Asia-Pac Weekly Risk Arb Wrap: Perpetual, Nitro, Fengxiang, Pushpay, Singapore Medical

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Perpetual, Nitro, Fengxiang, Pushpay, Singapore Medical

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief South Korea: Millie’s Library and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Millie’s Library IPO Valuation Analysis

Millie’s Library IPO Valuation Analysis

By Douglas Kim

  • Our base case valuation of the company is target price of 26,404 won per share, which represents 6% higher than the high end of the IPO price range.
  • Given the low upside, we have a Negative view of this IPO.
  • All in all, while we believe Millie’s Library is a solid company with excellent fundamentals, the IPO price range is not valued at meaningful discount to the intrinsic value.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief United States: DoorDash Inc and more

By | Daily Briefs, United States

In today’s briefing:

  • Doordash 3Q22: Is DASH the COVID Winner?

Doordash 3Q22: Is DASH the COVID Winner?

By Aaron Gabin

  • Strong growth continues….GOV grew 30%, 2% ahead of consensus..no macro headwinds.
  • New “disclosures” imply the core business is more profitable then presumed, rationalizing management’s investments in new businesses.
  • Beat and Raise…one of the few online platforms to do this in the current environment…in a business (food delivery) that most didn’t think was habitual LT.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars